Performance and model of a novel multi-sparger multi-stage airlift loop membrane bioreactor to treat high-strength 7-ACA pharmaceutical wastewater: effect of hydraulic retention time, temperature and pH

Hydrodynamics and mass transfer of concentric-tube internal loop airlift reactors: A review

The concentric-tube internal loop airlift reactor is a typical reactor configuration which has been adopted for a myriad of chemical and biological processes. The reactor hydrodynamics (including mixing) and the mass transfer between the gas and liquid phases remarkably affect the operational conditions and thus are crucial to the overall reactor performance. Hence, this study aims at providing a thorough description of the basic concepts and a comprehensive review of the relevant reported studies on the hydrodynamics and mass transfer of the concentric-tube internal loop airlift reactors, taking microalgae cultivation as an exemplary application. In particular, the reactor characteristics, geometry, CFD modeling, experimental characterization, and scale up considerations are elucidated. The research gaps for future research and development are also identified.

Computational Fluid Dynamics Simulation of Hydrodynamics in a Two-Stage Internal Loop Airlift Reactor with Contraction-Expansion Guide Vane

Global circulation and liquid back mixing adversely affect the continuous production of a multistage internal airlift loop reactor. A contraction-expansion guide vane (CEGV) is proposed and combined with a two-stage internal loop airlift reactor (TSILALR) to suppress the liquid back mixing between stages. A computational fluid dynamics (CFD) simulation is conducted to evaluate the performance of the CEGV in the TSILALR. The bubble size distribution and turbulent flow properties in the TSILALR are considered in the CFD simulation by using the population balance model and RNG k-ε turbulence model. The CFD model is validated against the experimental results. The deviations in the gas holdup and mean bubble diameter between the simulation and experimental results are less than 8% and 6%, respectively. The streamlines, flow pattern, bubble size distribution, and axial liquid velocity in the TSILALRs with and without the CEGV at superficial velocities of 0.04 and 0.08 m/s are obtained by CFD simulation. It has been shown that the CEGV generated local circulation flows at each stage instead of a global circulation flow in the TSILALR. The average global gas holdup in the TSILALR with a CEGV increased up to 1.98 times. The global gas holdup increased from 0.045 to 0.101 and the average axial velocity in the riser decreased from 0.314 to 0.241 m/s when the width of the CEGV increased from 50 to 75 mm at the superficial gas velocity of 0.08 m/s.

Multiple draft tubes airlift loop membrane bioreactor as an efficient system for acidic 7-amino cephalosporanic acid (7-ACA) wastewater treatment

In this study, a lab-scale multiple draft tubes airlift loop membrane bioreactor (Mt-ALMBR) was used for treating acidic 7-amino cephalosporanic acid (7-ACA) wastewater under different pHs (3.54-6.20) and hydraulic retention time (HRT) (48 h, 36 h, 24 h and 16 h). During about 200 days operation, under HRT of 48 h and pH condition about 6.0, the optimum average COD and BOD₅ removal rates were reach to 84.4 ± 2.1% and 94.9 ± 0.8%, and the highest 7-ACA removal rate also observed as 77.6%. Biodegradation, membrane rejection, hydrolysis and sludge adsorption were the four main pathways of 7-ACA removal. With the increase of pH, biodegradation, membrane rejection and hydrolysis had significant positive impacts on 7-ACA removal, while adsorption had a negative impact. Moreover, mathematical models for 7-ACA removal rate and pH were calculated to guide the operation of Mt-ALMBR. Biodegradation was the main pathway to remove 7-ACA when pH was >4.17.

Effect of hydraulic retention time on pollutants removal from real ship sewage treatment via a pilot-scale air-lift multilevel circulation membrane bioreactor

Developing a real ship sewage treatment system that not only satisfies the requirement of small space onboard but also meets the latest emission standards of International Maritime Organization (IMO) is still a challenging task for ship industry. To overcome these problems, in this study, a novel pilot-scale air-lift multilevel circulation membrane bioreactor (AMCMBR) was used to explore the effect of hydraulic retention time (HRT) on effluent chemical oxygen demand (COD) and total nitrogen (TN) while treating real ship sewage. Results indicated that the satisfactory removal efficiencies of COD and TN was achieved in the former stages (Re(COD) = 91.57% and 87.82%; Re(TN) = 77.17% and 81.19%). When HRT decreased to 4 h, the removal efficiencies of COD and TN was 86.93% and 70.49% respectively, which still met the strict IMO discharge standards. This mainly because the biofilm-assistant membrane filtration lead to the increase of physical removal rate. The high ratio of mixed liquor volatile suspended solids (MLVSS)/mixed liquid suspended solids (MLSS) (i.e. 0.75) indicated a high biomass content in the attached sludge and resulted into perfect pollutants removal effort. The compliance rate of COD and TN was 100% and 89%, respectively, which indicated stable operation of the pilot-scale AMCMBR throughout the whole experiment. Fluorescence in situ Hybridization (FISH) analysis revealed that the abundance of β-Proteobacteria was a key microbial reason for TN removal. In addition, wavelet neural network (WNN) model was proved to be suitable to simulate and predict the COD and TN removal. These conclusions indicated that the pilot-scale AMCMBR technology is an effective way for real ship sewage treatment.

Fate of pharmaceuticals during membrane bioreactor treatment: Status and perspectives

Pharmaceuticals in surface waters and wastewater treatment plants (WWTPs) as emerging pollutants have become a major concern. In comparison with other wastewater treatments, removal of pharmaceuticals in MBR has received much attention. This review presents the source and occurrence of pharmaceuticals in WWTPs influents. Experimental studies related to the removal of pharmaceuticals during MBR treatment, key affecting factors (including the different stages of MBR process configuration and the process parameters), and the underlying mechanisms proposed to explain the biodegradation and adsorption behaviors, have been comprehensively discussed. Several transformation products of pharmaceuticals are also reviewed in this paper. Furthermore, further research is needed to gain more information about the multiple influence factors of the pharmaceuticals elimination, appropriate methods for promoting pharmaceuticals elimination, more essential removal pathways, effect of pharmaceuticals on membrane fouling, and the detection and analysis of transformation products.

Removal of cephalosporin antibiotics 7-ACA from wastewater during the cultivation of lipid-accumulating microalgae

The aim of this study is to evaluate the feasibility of using lipid-accumulating microalgae to remove cephalosporin antibiotics 7-amino cephalosporanic acid (7-ACA) from wastewater with the additional benefit of biofuels production. Three isolated microalgal strains (namely, Chlorella sp. Cha-01, Chlamydomonas sp. Tai-03 and Mychonastes sp. YL-02) were cultivated under 7-ACA stress and their biomass productivity, lipid production and N-NO₃^- consumption were monitored. It was found that 7-ACA had slight inhibition effects on the microalgal growth at the ratio of 12.0% (Cha-01), 9.6% (YL-02), 11.7% (Tai-03). However, lipid accumulation in the three microalgae was not influenced by the presence of 7-ACA. The investigation on the 7-ACA removal mechanisms during microalgal growth shows that 7-ACA was mainly removed by microalgae adsorption as well as hydrolysis and photolysis reactions. This study demonstrates that using microalgae to treat antibiotic-containing wastewater is promising due to the potential of simultaneous antibiotic removal and biofuel production.

Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia

The concentrations of 12 pharmaceutical compounds (atenolol, erythromycin, cyclophosphamide, paracetamol, bezafibrate, carbamazepine, ciprofloxacin, caffeine, clarithromycin, lidocaine, sulfamethoxazole and N-acetylsulfamethoxazol (NACS)) were investigated in the influents and effluents of two hospital wastewater treatment plants (HWWTPs) in Saudi Arabia. The majority of the target analytes were detected in the influent samples apart from bezafibrate, cyclophosphamide, and erythromycin. Caffeine and paracetamol were detected in the influent at particularly high concentrations up to 75 and 12 ug/L, respectively. High removal efficiencies of the pharmaceutical compounds were observed in both HWWTPs, with greater than 90 % removal on average. Paracetamol, sulfamethoxazole, NACS, ciprofloxacin, and caffeine were eliminated by between >95 and >99 % on average. Atenolol, carbamazepine, and clarithromycin were eliminated by >86 % on average. Of particular interest were the high removal efficiencies of carbamazepine and antibiotics that were achieved by the HWWTPs; these compounds have been reported to be relatively recalcitrant to biological treatment and are generally only partially removed. Elevated temperatures and high levels of sunlight were considered to be the main factors that enhanced the removal of these compounds.

Membrane bioprocesses for pharmaceutical micropollutant removal from waters

The purpose of this review work is to give an overview of the research reported on bioprocesses for the treatment of domestic or industrial wastewaters (WW) containing pharmaceuticals. Conventional WW treatment technologies are not efficient enough to completely remove all pharmaceuticals from water. Indeed, these compounds are becoming an actual public health problem, because they are more and more present in underground and even in potable waters. Different types of bioprocesses are described in this work: from classical activated sludge systems, which allow the depletion of pharmaceuticals by bio-degradation and adsorption, to enzymatic reactions, which are more focused on the treatment of WW containing a relatively high content of pharmaceuticals and less organic carbon pollution than classical WW. Different aspects concerning the advantages of membrane bioreactors for pharmaceuticals removal are discussed, as well as the more recent studies on enzymatic membrane reactors to the depletion of these recalcitrant compounds.